The Role of Aplnr Signaling in the Developmental Regulation of Mesenchymal Stem Cell Differentiation from Human Pluripotent Stem Cells

被引:0
|
作者
Sisli, Hatice Burcu [1 ]
Senkal Turhan, Selinay [1 ]
Bulut, Ezgi [1 ]
Sahin, Fikrettin [1 ]
Dogan, Aysegul [1 ]
机构
[1] Yeditepe Univ, Fac Engn, Genet & Bioengn Dept, TR-34755 Istanbul, Turkiye
来源
ADVANCED BIOLOGY | 2024年 / 8卷 / 01期
关键词
Aplnr signaling; cell migration; mesoderm; MSC differentiation; pluripotent stem cells; OSTEOGENIC DIFFERENTIATION; GENE-EXPRESSION; ORIGIN; PROGENITORS; COMMITMENT; PATHWAY; ELABELA; PANTHER; HTGSCS; TOOL;
D O I
10.1002/adbi.202300217
中图分类号
TB3 [工程材料学]; R318.08 [生物材料学];
学科分类号
0805 ; 080501 ; 080502 ;
摘要
Stem cells are invaluable resources for personalized medicine. Mesenchymal stem cells (MSCs) have received great attention as therapeutic tools due to being a safe, ethical, and accessible option with immunomodulatory and controlled differentiation properties. Apelin receptor (Aplnr) signaling is reported to be involved in biological events, including gastrulation, mesoderm migration, proliferation of MSCs. However, the knowledge about the exact role and mechanism of Aplnr signaling during mesoderm and MSCs differentiation is still primitive. The current study aims to unveil the role of Aplnr signaling during mesoderm and MSC differentiation from pluripotent stem cells (PSCs) through peptide/small molecule activation, overexpression, knock down or CRISPR/Cas9 mediated knock out of the pathway components. Morphological changes, gene and protein expression analysis, including antibody array, LC/MS, mRNA/miRNA sequencing, reveal that Aplnr signaling promotes mesoderm commitment possibly via EGFR and TGF-beta signaling pathways and enhances migration of cells during mesoderm differentiation. Moreover, Aplnr signaling positively regulates MSCs differentiation from hPSCs and increases MSC characteristics and differentiation capacity by regulating pathways, such as EGFR, TGF beta, Wnt, PDGF, and FGF. Osteogenic, chondrogenic, adipogenic, and myogenic differentiations are significantly enhanced with Aplnr signaling activity. This study generates an important foundation to generate high potential MSCs from PSCs to be used in personalized cell therapy. Human pluripotent stem cell (hPSC) derived mesodermal progeniors, as a major source of MSCs, have a high proliferation and differentiation capacity in culture. Activation of Apelin receptor (Aplnr) signaling at mesoderm stages upregulates certain molecular pathways and important genes including Bra, Flk-1, and PDGFR alpha. These pathways regulates mesenchymal stem cell differentiation in culture upon activation of Aplnr signaling.image
引用
收藏
页数:21
相关论文
共 50 条
  • [41] Comparative analysis of human induced pluripotent stem cell-derived mesenchymal stem cells and umbilical cord mesenchymal stem cells
    Rajasingh, Sheeja
    Sigamani, Vinoth
    Selvam, Vijay
    Gurusamy, Narasimman
    Kirankumar, Shivaani
    Vasanthan, Jayavardini
    Rajasingh, Johnson
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2021, 25 (18) : 8904 - 8919
  • [42] Pluripotent marker expression and differentiation of human second trimester Mesenchymal Stem Cells
    Gonzalez, R.
    Maki, C. B.
    Pacchiarotti, J.
    Csontos, S.
    Pham, J. K.
    Slepko, N.
    Patel, A.
    Silva, F.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2007, 362 (02) : 491 - 497
  • [43] Inhibition of FGF signaling accelerates neural crest cell differentiation of human pluripotent stem cells
    Jaroonwitchawan, Thiranut
    Muangchan, Pattamon
    Noisa, Parinya
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2016, 481 (1-2) : 176 - 181
  • [44] Application of mesenchymal stem cells derived from human pluripotent stem cells in regenerative medicine
    Liu, Tong-Ming
    WORLD JOURNAL OF STEM CELLS, 2021, 13 (12): : 1826 - 1844
  • [45] Regulation of Cardiomyocyte Differentiation, Angiogenesis, and Inflammation by the Delta Opioid Signaling in Human Mesenchymal Stem Cells
    Reddy, L. Vinod Kumar
    Sen, Dwaipayan
    REGENERATIVE ENGINEERING AND TRANSLATIONAL MEDICINE, 2019, 5 (03) : 252 - 262
  • [46] Regulation of Cardiomyocyte Differentiation, Angiogenesis, and Inflammation by the Delta Opioid Signaling in Human Mesenchymal Stem Cells
    L. Vinod Kumar Reddy
    Dwaipayan Sen
    Regenerative Engineering and Translational Medicine, 2019, 5 : 252 - 262
  • [47] ONE STEP DERIVATION OF CARDIOMYOCYTES AND MESENCHYMAL STEM CELLS FROM HUMAN PLURIPOTENT STEM CELLS
    Wei, Heming
    Tan, Grace
    Manasi, Manasi
    Yong, Pearly
    Koh, Cai Hong
    Ooi, Ting Huay
    Lim, Sze Yun
    Wong, Philip
    Gan, Shu Uin
    Shim, Winston
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (13) : E1391 - E1391
  • [48] Developmental principles informing human pluripotent stem cell differentiation to cartilage and bone
    Humphreys, Paul A.
    Mancini, Fabrizio E.
    Ferreira, Miguel J. S.
    Woods, Steven
    Ogene, Leona
    Kimber, Susan J.
    SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2022, 127 : 17 - 36
  • [49] Glycans in stem cell regulation: from Drosophila tissue stem cells to mammalian pluripotent stem cells
    Nishihara, Shoko
    FEBS LETTERS, 2018, 592 (23): : 3773 - 3790
  • [50] Purinergic signaling in mesenchymal stem cell differentiation
    Tobiasch, E.
    Hielscher, D.
    Ottensmeyes, P.
    Babcyzk, P.
    Zhang, Y.
    Schulze, M.
    PURINERGIC SIGNALLING, 2018, 14 : S41 - S41